We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.86B
AUM Growth
-$273M
Cap. Flow
-$421M
Cap. Flow %
-14.72%
Top 10 Hldgs %
69.14%
Holding
77
New
3
Increased
6
Reduced
39
Closed
29

Top Buys

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$93M
2
MDT icon
Medtronic
MDT
+$46.8M
3
WTW icon
Willis Towers Watson
WTW
+$15.7M
4
ALIT icon
Alight
ALIT
+$15.5M
5
MAS icon
Masco
MAS
+$12.4M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$92.7M
2
BKNG icon
Booking.com
BKNG
+$83.4M
3
BAP icon
Credicorp
BAP
+$77.1M
4
CHKP icon
Check Point Software Technologies
CHKP
+$57.6M
5
CTSH icon
Cognizant
CTSH
+$19.5M

Sector Composition

Rank Sector Weight
1 Financials 41.12%
2 Communication Services 13.39%
3 Technology 13%
4 Healthcare 10.95%
5 Energy 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKD icon
51
Brookdale Senior Living
BKD
$3.34B
-442,452
Closed -$2.28M
BKNG icon
52
Booking.com
BKNG
$149B
-868,825
Closed -$83.4M
CABA icon
53
Cabaletta Bio
CABA
$448M
-140,000
Closed -$531K
CI icon
54
Cigna
CI
$72.6B
-23,300
Closed -$5.35M
CTMX icon
55
CytomX Therapeutics
CTMX
$708M
-120,000
Closed -$520K
DCTH icon
56
Delcath Systems
DCTH
$456M
-90,000
Closed -$698K
ELV icon
57
Elevance Health
ELV
$82.2B
-10,100
Closed -$4.68M
EXC icon
58
Exelon
EXC
$46.5B
-261,275
Closed -$10.8M
FATE icon
59
Fate Therapeutics
FATE
$287M
-27,000
Closed -$1.58M
GILD icon
60
Gilead Sciences
GILD
$163B
-45,000
Closed -$3.27M
HR icon
61
Healthcare Realty
HR
$7.05B
-528,617
Closed -$17.7M
JAZZ icon
62
Jazz Pharmaceuticals
JAZZ
$16.1B
-21,000
Closed -$2.67M
KR icon
63
Kroger
KR
$35B
-320,324
Closed -$14.5M
KURA icon
64
Kura Oncology
KURA
$833M
-110,000
Closed -$1.54M
KZR
65
DELISTED
Kezar Life Sciences
KZR
-10,000
Closed -$1.67M
LNTH icon
66
Lantheus
LNTH
$6.58B
-110,000
Closed -$3.18M
MGNX icon
67
MacroGenics
MGNX
$244M
-70,000
Closed -$1.12M
NVST icon
68
Envista
NVST
$4.5B
-50,000
Closed -$2.25M
PRQR icon
69
ProQR Therapeutics
PRQR
$255M
-321,360
Closed -$2.57M
SGMO
70
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-216,500
Closed -$1.62M
XENE icon
71
Xenon Pharmaceuticals
XENE
$6.12B
-170,000
Closed -$5.31M
ITCI
72
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-80,000
Closed -$4.19M
MORF
73
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-68,485
Closed -$3.25M
ICPT
74
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-168,800
Closed -$2.75M
SPNE
75
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-552,274
Closed -$7.52M

Similar funds

Altrinsic Global Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Altrinsic Global Advisors held 77 positions worth $2.86B, down 8.7% from $3.13B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Altrinsic Global Advisors withdrew a net $421M in Q1 2022, closing 29 positions and reducing 39 holdings. Its most notable exit was Booking.com, an estimated $83.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 38% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Altrinsic Global Advisors opened a new position in HDFC Bank worth $87.7M.

  • Altrinsic Global Advisors's largest Q1 2022 buy was HDFC Bank: 2,861,144 shares worth $87.7M.
  • Altrinsic Global Advisors added most to Medtronic in Q1 2022, an estimated $46.8M increase.
  • Altrinsic Global Advisors's biggest Q1 2022 reduction was Chubb, cutting an estimated $92.7M.
  • Altrinsic Global Advisors fully exited Booking.com in Q1 2022, selling an estimated $83.4M.
  • Altrinsic Global Advisors's ten largest holdings make up 69% of its $2.86B portfolio in Q1 2022.
  • Altrinsic Global Advisors opened 3 new positions and closed 29 in Q1 2022.
  • Altrinsic Global Advisors's portfolio value fell 8.7% quarter-over-quarter to $2.86B.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.